KANJINTI vs TEPYLUTE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. KANJINTI and TEPYLUTE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KANJINTI	TEPYLUTE
Rating	72/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TRASTUZUMAB-ANNS	THIOTEPA
Manufacturer	Amgen Inc	Shorla
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms

kanjinti tepylute

Rating

72/100

New

Pharmacy pays

—

Type

Active ingredient

TRASTUZUMAB-ANNS

THIOTEPA

Manufacturer

Amgen Inc

Shorla

Dosage forms

Injectable

Drug class

—

Boxed warning

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms

Frequently asked questions

What is the difference between Kanjinti and Tepylute?

Kanjinti contains Trastuzumab-Anns, while Tepylute contains Thiotepa — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.